Review Article

Genetic Variants in SNCA and the Risk of Sporadic Parkinson’s Disease and Clinical Outcomes: A Review

Table 1

Characterization of the reviewed studies.

StudiesStudy IDCountry of participantsSample sizeOnset age
PDCtr

Davila-Ortiz de Montellano et al., 2016[27]Mexico171171
Davis et al., 2016[28]USA418150
García et al., 2016[29]Mexico106135
Shahmohammadibeni et al., 2016[30]Iran489489
Wang et al., 2016[31]China296
Cheng et al., 2016[32]China10531152
Guella et al., 2016[33]Multicentric1492971
Chen et al., 2015[34]China218110
Huang et al., 2015[35]China, Australia402
Han et al., 2015[36]China9192
Chen et al., 2015[37]China1276846
Gao et al., 2015[38]USA5071330
Cardo et al., 2014[39]China752489
Guo et al., 2014[40]China1011721
Pan et al., 2013[41]China515450
Mata et al., 2014[42]USA1191
Markopoulou et al., 2014[43]USA109862.2
Emelyanov et al., 2013[44]Russia244308
Wu-Chou et al., 2013[45]Taiwan626473
Brockmann et al., 2013[46]Germany1396
Chung et al., 2013[47]USA1098109860.4
Pihlstrøm et al., 2013[48]Norway and Sweden1380129559.0
Heckman et al., 2012[49]USA426769
Ritz et al., 2012[50]USA232
Schmitt et al., 2012[51]Germany9801005
Miyake et al., 2012[52]Japan229357
Pan et al., 2012[53]China403315
Cardo et al., 2012[54]Spain727480
Gao et al., 2012[55]USA5841571
Trotta et al., 2012[56]Italy904891
Hu et al., 2012[57]China110136
Botta-Orfilla et al., 2012[58]Spain84
Mata et al., 2011[59]Spain14451161
Chung et al., 2011[60]USA1103110362.2
Elbaz et al., 2011[61]Multicentric53024161
Wider er al., 2011[62]USA, Ireland, Norway10201095
Botta-Orfilla et al., 2011[63]Spain757708
Biernacka et al., 2011[64]USA1098109862.2
Mata et al., 2010[65]USA19562112
Yu et al., 2010[66]China332300
Hu et al., 2010[67]China330300
Gatto et al., 2010[68]USA333336
Rajput et al., 2009[69]Canada452245
Sutherland et al., 2009[70]Australia331296
Brighina et al., 2009[71]USA89389362.1
Kay et al., 2008[72]USA18022192
Myhre et al., 2008[73]Netherlands236236
Verbaan et al., 2008[74]Netherlands295150
Brighina et al., 2008[75]USA83383361.9
Ross et al., 2007[76]Ireland186186
Winkler et al., 2007[77]Germany, Serbia397270
Goris et al., 2007[78]UK659217663.0
Hadjigeorgiou et al., 2006[79]Greece178186
Mueller et al., 2005[80]Germany6691002
Mamah et al., 2005[81]USA55755763.0
Spadafora et al., 2003[82]Italy186182
Izumi et al., 2001[83]Japan200250

ID: identification; PD: Parkinson’s disease group; Ctr: control group; SD: standard deviation. The countries of origin of participants were New Zeeland, Canada, UK, and USA. The countries of origin of participants were Australia, France, Germany, Greece, Ireland, Italy, Norway, Poland, Sweden, and USA.